Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Selegiline (Zelapar) and Rytary (carbidopa/levodopa) are both used to treat Parkinson's disease (PD), but they work in different ways and have different uses. Selegiline is a monoamine oxidase type B (MAO-B) inhibitor that helps prevent the breakdown of dopamine in your brain, extending the effects of levodopa. It's used as an add-on treatment for people already taking carbidopa/levodopa medications like Rytary. On the other hand, Rytary is a combination of carbidopa and levodopa that directly replaces dopamine in your brain and is used to treat PD symptoms like stiffness and slowed movement. Selegiline is available in tablets, capsules, and orally disintegrating tablets (ODTs), while Rytary is an extended-release capsule taken three times a day. Selegiline can cause high blood pressure if you eat foods high in tyramine, while Rytary can cause heart problems and may raise your risk for stomach bleeding. Selegiline is available in a generic form, but Rytary is not, which can make Rytary more expensive.
Selegiline
Rytary (carbidopa / levodopa)
Selegiline
Rytary (carbidopa / levodopa)
Summary of Zelapar vs. Rytary
Summary for MAO-B inhibitor
Prescription only
Selegiline helps relieve symptoms of Parkinson's disease in people who have "off" episodes as their carbidopa/levodopa medication starts to wear off. Selegiline is a type of monoamine oxidase inhibitor (MAOI), which is a drug class that has many drug interactions. Generic selegiline tablets and capsules are taken twice per day; the brand name for the pills, Eldepryl, is no longer available. Selegiline also comes as orally disintegrating tablets (ODTs) under the brand name Zelapar that are dissolved on the tongue once per day. Side effects include changes in blood pressure, nausea, and dizziness.
Summary for Dopa decarboxylase inhibitor / Dopamine replacement
Prescription only
Rytary (carbidopa / levodopa) is a combination medication that's used to treat adults with symptoms of Parkinson's disease (PD), such as stiff muscles and slowed movement. It contains carbidopa (a decarboxylase inhibitor) and levodopa (a dopamine replacement) in an extended-release capsule. The typical dosage is one capsule by mouth three times a day. Common side effects include nausea, headache, and dizziness. This medication doesn't currently have a generic version, but you can get it under the brand name Rytary.